Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trialResearch in context

Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trialResearch in context

Summary: Background: Smoking cessation is challenging, despite making use of established smoking cessation therapies. Preclinical studies and one clinical pilot study suggest the antidiabetic drug glucagon-like peptide-1 (GLP-1) analogue to modulate addictive behaviours and nicotine craving. Previo...

詳細記述

書誌詳細
主要な著者: Hualin Lüthi, Sophia Lengsfeld, Thilo Burkard, Andrea Meienberg, Nica Jeanloz, Tanja Vukajlovic, Katja Bologna, Michelle Steinmetz, Cemile Bathelt, Clara O. Sailer, Mirjam Laager, Deborah R. Vogt, Lars G. Hemkens, Benjamin Speich, Sandrine A. Urwyler, Jill Kühne, Fabienne Baur, Linda N. Lutz, Tobias E. Erlanger, Mirjam Christ-Crain, Bettina Winzeler
フォーマット: 論文
言語:English
出版事項: Elsevier 2024-02-01
シリーズ:EClinicalMedicine
主題:
Glucagon-like peptide-1 (GLP-1) analogues
Quitting smoking
Long-term abstinence
Post-cessation weight gain
オンライン･アクセス:http://www.sciencedirect.com/science/article/pii/S2589537024000087

インターネット

http://www.sciencedirect.com/science/article/pii/S2589537024000087

類似資料